Home
>
National Drug Code (NDC)
>
Ranitidine
Ranitidine - 0472-0383-16 - (Ranitidine)
Drug Information of Ranitidine
| Product NDC: | 0472-0383 |
| Proprietary Name: | Ranitidine |
| Non Proprietary Name: | Ranitidine |
| Active Ingredient(s): | 15 mg/mL & nbsp; Ranitidine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | SOLUTION |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Ranitidine
| Product NDC: | 0472-0383 |
| Labeler Name: | Actavis Mid Atlantic LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | ANDA076124 |
| Marketing Category: | ANDA |
| Start Marketing Date: | 20070315 |
Package Information of Ranitidine
| Package NDC: | 0472-0383-16 |
| Package Description: | 473 mL in 1 BOTTLE (0472-0383-16) |
NDC Information of Ranitidine
| NDC Code | 0472-0383-16 |
| Proprietary Name | Ranitidine |
| Package Description | 473 mL in 1 BOTTLE (0472-0383-16) |
| Product NDC | 0472-0383 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | Ranitidine |
| Dosage Form Name | SOLUTION |
| Route Name | ORAL |
| Start Marketing Date | 20070315 |
| Marketing Category Name | ANDA |
| Labeler Name | Actavis Mid Atlantic LLC |
| Substance Name | RANITIDINE HYDROCHLORIDE |
| Strength Number | 15 |
| Strength Unit | mg/mL |
| Pharmaceutical Classes | Histamine H2 Receptor Antagonists [MoA],Histamine-2 Receptor Antagonist [EPC] |
